This new drug could break cancer’s resistance to treatment
5 Articles
5 Articles
Researchers from the Baylor College of Medicine in the United States developed a experimental drug called CS18 that demonstrated in pre-bed trials the ability to weaken mechanisms that help cancer cells resist treatment, which could pave the way for the development of new methods for dealing with certain drug-resistant tumours.
This new drug could break cancer’s resistance to treatment
A new experimental drug called CS18 may help break through cancer drug resistance by disabling several of the defenses tumors use to survive treatment. It strengthened existing therapies, restored drug sensitivity in resistant lung cancer cells, and slowed tumor growth in animal models.
The experimental compound enhanced the effects of existing therapies and slowed the growth of tumors in animals. Human trials are yet to come
The most promising drug against cancer resistance does not affect cancer: it affects its control system. The article Baylor discovers a way to disarm the tumor before it defends itself is taken from the Future Next.
Researchers at Baylor College of Medicine have developed a new experimental drug called CS18, which can help overcome resistance to cancer treatment. The study, published in Science Advances, presents evidence...
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
